Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole for Invasive Fungal Infections in Immunocompromised Hosts
NCT00034671Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2001
- Primary completion
- Nov 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of posaconazole in mycosis, sponsored by Merck & Co.. Started Jan 2001; status: completed.
02
Drugs
posaconazole
03
Conditions
mycosis
Beyond the preview
Go deeper on NCT00034671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034671.